LAUREN MARASA: Open Payments
NPI 1003175415 · FOLSOM, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,138 in 24 payments from 8 companies in 2025. Trend: 2023 $2,318 · 2024 $1,232 · 2025 $1,138
Food & beverage: $1,138
| Company | Payments | Amount |
|---|---|---|
| Neuronetics, Inc. | 9 | $689 |
| Axsome Therapeutics, Inc. | 2 | $156 |
| Janssen Pharmaceuticals, Inc | 4 | $95 |
| Bausch Health US, LLC | 3 | $63 |
| Neurocrine BioSciences, Inc. | 2 | $47 |
| Sage Therapeutics, LLC | 2 | $44 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
Products named: NEUROSTAR TMS THERAPY SYSTEM, Auvelity, SPRAVATO, APLENZIN, INGREZZA, ZURZUVAE, AUSTEDO XR, CAPLYTA.
Industry payments across CA — which companies pay providers there.
